InvestorsHub Logo
Followers 0
Posts 438
Boards Moderated 0
Alias Born 09/22/2010

Re: Nanotoday post# 38830

Sunday, 10/03/2010 7:43:50 PM

Sunday, October 03, 2010 7:43:50 PM

Post# of 146242
Let's see some viral log curves. HAART has no delivery issue with respect to ADME. For humans, we've reached the final frontier for HIV therapy - clearing the virus from the blood is easily achievable with one pill (Atripla) - we need something that will clear it from the reservoirs where the antivirals can't reach.

From Seymour's comments ("we don't work inside cells") and his comment at 8:00 where he notes "that's a whole other project" with respect to tackling herpes virus which is hidden latent in nerve cells, I suspect NNVC does not have the technology to tackle HIV. The facts are simple.

Rabies? That seems interesting.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News